Literature DB >> 2420406

Inotropic effects of Ca2+ channel agonist and antagonists in neuraminidase-treated left atria of rats.

Y Hattori, S Hazama, M Kanno, Y Nakao.   

Abstract

The effects of removal of sialic acid from cardiac sarcolemma on contractile functions and on inotropic responses to Ca2+ channel agonist and antagonists were investigated in rat left atria. About 64% of the total sialic acid content of the left atria was removed during a 90 min exposure to neuraminidase (2 u ml-1). The removal of sialic acid neither affected the development of twitch tension induced by stimulation at a frequency of 0.5 Hz, nor altered the interval-dependent changes in contractility such as the force-frequency relationship and post rest contractions. The positive inotropic effects produced by isoprenaline, and by an increase in extracellular Ca2+ concentration were the same in the neuraminidase-treated preparations as those in the untreated preparations. Bay K 8644, a Ca2+ channel agonist, induced an increase in contractility in the neuraminidase-treated preparations comparable to that in the untreated ones. Neuraminidase treatment significantly attenuated the negative inotropic effects of verapamil and diltiazem, whereas it had no effect on that of nifedipine. The results indicate that sialic acid removal modifies neither the basal contractile functions nor the positive inotropism which is associated with an enhancement of the slow inward Ca2+ current. However, sialic acid, which constitutes the glycocalyx of the cardiac sarcolemma, may be involved in the mechanism of the Ca2+ channel antagonistic actions of verapamil and diltiazem, but not that of nifedipine. Thus, our results provide pharmacological evidence that verapamil and diltiazem behave differently from the dihydropyridine compounds.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420406      PMCID: PMC1916552          DOI: 10.1111/j.1476-5381.1986.tb10818.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Studies of the contractility of mammalian myocardium at low rates of stimulation.

Authors:  D G Allen; B R Jewell; E H Wood
Journal:  J Physiol       Date:  1976-01       Impact factor: 5.182

2.  Glycocalyx is not required for show inward calcium current in isolated rat heart myocytes.

Authors:  G Isenberg; U Klöckner
Journal:  Nature       Date:  1980-03-27       Impact factor: 49.962

Review 3.  Excitation-contraction coupling in cardiac muscle.

Authors:  R A Chapman
Journal:  Prog Biophys Mol Biol       Date:  1979       Impact factor: 3.667

4.  Correlation of calcium exchange, structure, and function in myocardial tissue culture.

Authors:  G A Langer; J S Frank; L M Nudd
Journal:  Am J Physiol       Date:  1979-08

5.  The myocardial cell surface, its histochemistry, and the effect of sialic acid and calcium removal on its stucture and cellular ionic exchange.

Authors:  J S Frank; G A Langer; L M Nudd; K Seraydarian
Journal:  Circ Res       Date:  1977-11       Impact factor: 17.367

6.  Neuraminidase dissociates ouabain inotropy from toxicity.

Authors:  L E Bailey; A B Fawzi
Journal:  J Mol Cell Cardiol       Date:  1980-05       Impact factor: 5.000

7.  Functional deficiencies in interstitial glycoproteins in myopathic hamster hearts.

Authors:  L E Bailey; T S Ma
Journal:  Adv Myocardiol       Date:  1980

8.  Removal of sialic acid from cardiac sarcolemma does not affect contractile function in electrically stimulated guinea pig left atria.

Authors:  S E Harding; J Halliday
Journal:  Nature       Date:  1980-08-21       Impact factor: 49.962

9.  Localization of beta adrenergic receptors, and effects of noradrenaline and cyclic nucleotides on action potentials, ionic currents and tension in mammalian cardiac muscle.

Authors:  H Reuter
Journal:  J Physiol       Date:  1974-10       Impact factor: 5.182

10.  The effect of verapamil on the Ca2+-transporting and Ca2+-ATPase activity of isolated cardiac sarcolemmal preparations.

Authors:  J Mas-Oliva; W G Nayler
Journal:  Br J Pharmacol       Date:  1980-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.